A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
The small intestine absorbs most nutrients via specific transporters: glucose and galactose by active transport, fructose by facilitated diffusion, amino acids by cotransporters. Fat is emulsified by bile and absorbed as monoglycerides and fatty acids, then resynthesized into triglycerides for packaging into chylomicrons. The intestinal epithelium continuously renews (every 3-5 days) and maintains a selective barrier via tight junctions.
From your earlier study of nutrient absorption and brush border digestion, you know that the small intestine breaks macromolecules into absorbable units — monosaccharides, amino acids, and lipid fragments — at the epithelial surface. The next question is: how do these molecules actually cross the intestinal wall and enter the bloodstream? The answer is not a single mechanism but a set of specific transport systems, each matched to the chemical properties of what it carries.
Carbohydrate absorption illustrates the principle clearly. Glucose and galactose are absorbed by SGLT1 (sodium-glucose linked transporter 1) on the apical (lumen-facing) membrane of enterocytes. This is secondary active transport: sodium ions flow down their concentration gradient (maintained by the Na⁺/K⁺-ATPase on the basolateral side), and glucose hitches a ride against its own gradient. Think of it like a revolving door powered by the sodium stream — glucose gets pulled through even when its concentration inside the cell is already higher than in the lumen. Once inside the enterocyte, glucose exits through GLUT2 transporters on the basolateral membrane into the capillary blood by facilitated diffusion. Fructose takes a different route entirely: it crosses the apical membrane via GLUT5 (facilitated diffusion, no sodium required) and exits basolaterally through GLUT2. This is why fructose absorption has a lower capacity than glucose absorption and why excessive fructose intake can overwhelm the system, causing osmotic diarrhea.
Fat absorption is fundamentally different because lipids are hydrophobic and cannot dissolve in the aqueous environment of the intestinal lumen. Bile salts (from the liver and gallbladder) solve this problem by forming mixed micelles — tiny aggregates with hydrophobic interiors that shuttle monoglycerides, fatty acids, cholesterol, and fat-soluble vitamins to the brush border surface. At the membrane, lipids diffuse out of the micelles and cross into the enterocyte (largely by passive diffusion, aided by fatty acid transport proteins). Inside the cell, the process reverses: monoglycerides and fatty acids are reassembled into triglycerides in the smooth endoplasmic reticulum, packaged with cholesterol and apolipoprotein B-48 into large lipoprotein particles called chylomicrons, and secreted into the lacteals (lymphatic capillaries) rather than directly into blood capillaries. This lymphatic route is necessary because chylomicrons are too large to enter blood capillaries directly; they eventually reach the bloodstream via the thoracic duct.
The intestinal epithelium that performs all this work is one of the most rapidly renewing tissues in the body, replacing itself every 3–5 days. Stem cells at the base of intestinal crypts continuously divide and produce new enterocytes that migrate upward along the villus, mature, perform their absorptive function, and are eventually shed from the villus tip into the lumen. This rapid turnover is both a strength — damaged epithelium heals quickly — and a vulnerability, because chemotherapy drugs that target rapidly dividing cells often cause severe intestinal side effects. The tight junctions between enterocytes form a selective barrier, allowing paracellular transport of water and small ions while preventing bacteria and large molecules from crossing. When these junctions are disrupted (by inflammation, infection, or conditions like celiac disease), the barrier fails and both absorption efficiency and immune protection are compromised.